BioCentury
ARTICLE | Clinical News

InSite regulatory update

May 13, 1996 7:00 AM UTC

INSV said the University of California received notice of allowance for a U.S. patent covering substantially purified nucleic acid molecules that encode for a human glaucoma-associated protein. INSV has exclusive worldwide rights to the patent. ...